[ad_1]
HIDA, Japan, Feb. 26, 2022 /PRNewswire/ — ALPS Pharmaceutical Ind. Co., Ltd. (President: Osamu Ushimaru), a global pharmaceutical company that pioneered the use of phytochemicals in medicine and food, announced the launch of a new Isoquercetin composition, Eubio®Isoquercetin, today. Eubio®Isoquercetin derived from Sophora Japonica is expected to deliver more Quercetin to the body via small doses of Isoquercetin.
Eubio®Isoquercetin, a water-soluble Isoquercetin composition, protected by three related US patents, demonstrated a significantly higher Quercetin absorbability rate than ordinary Isoquercetin in a human pharmacokinetics study. Eubio®Isoquercetin is only formulated with all natural food ingredients and is the first formula to achieve a higher absorption of Quercetin into the body without enzymatic modification.
“We have succeeded in applying…
Full story available on Benzinga.com
[ad_2]
Source link
